A detailed history of Ground Swell Capital, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Ground Swell Capital, LLC holds 11,919 shares of KRON stock, worth $11,680. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,919
Holding current value
$11,680
% of portfolio
0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$0.82 - $1.07 $9,773 - $12,753
11,919 New
11,919 $11,000
Q4 2023

Feb 13, 2024

BUY
$0.75 - $1.49 $11,445 - $22,737
15,260 New
15,260 $19,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $55.6M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Ground Swell Capital, LLC Portfolio

Follow Ground Swell Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ground Swell Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ground Swell Capital, LLC with notifications on news.